Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP).

Pharmacological Reports : PR
Houli JiangJohn C McGiff

Abstract

In addition to serving as carriers of O(2), red blood cells (RBCs) regulate vascular resistance and the distribution of microvascular perfusion by liberating adenosine triphosphate (ATP) and epoxyeicosatrienoic acids (EETs) upon exposure to a low O(2) environment. Therefore, RBCs act as sensors that respond to low pO(2) by releasing millimolar amounts of ATP, a signaling molecule, and lipid mediators (EETs). The release of EETs occurs by a mechanism that is activated by ATP stimulation of P2X(7) receptors coupled to ATP transporters, which should greatly amplify the circulatory response to ATP. RBCs are reservoirs of EETs and the primary sources of plasma EETs, which are esterified to the phospholipids of lipoproteins. Levels of free EETs in plasma are low, about 3% of circulating EETs. RBC EETs are produced by direct oxidation of arachidonic acid (AA) esterified to glycerophospholipids and the monooxygenase-like activity of hemoglobin. On release, EETs affect vascular tone, produce profibrinolysis and dampen inflammation. A soluble epoxide hydrolase (sEH) regulates the concentrations of RBC and vascular EETs by metabolizing both cis- and trans-EETs to form dihydroxyeicosatrienoic acids (DHETs). The function and pathophysiologi...Continue Reading

References

Jul 31, 1987·Biochemical and Biophysical Research Communications·J H CapdevilaJ R Falck
Feb 11, 1982·Biochemical and Biophysical Research Communications·N ChacosJ Capdevila
Oct 16, 1999·Nature·B FisslthalerR Busse
Mar 31, 2000·Trends in Pharmacological Sciences·W B Campbell
Apr 6, 2000·American Journal of Physiology. Heart and Circulatory Physiology·D H Munzenmaier, D R Harder
Sep 26, 2000·The Journal of Biological Chemistry·C J SinalF J Gonzalez
Feb 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Benjamin B DavisRobert H Weiss
Nov 26, 2003·Progress in Lipid Research·Arthur A SpectorNeal L Weintraub
Jun 24, 2004·The Journal of Biological Chemistry·Houli JiangPatrick Y-K Wong
Jul 31, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Xiang FangArthur A Spector
Oct 12, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Eric O Feigl
Nov 19, 2004·International Review of Cytology·Geoffrey Burnstock, Gillian E Knight
Nov 26, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Martin FariasEric O Feigl
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kevin R SmithBruce D Hammock
Mar 26, 2005·Prostaglandins & Other Lipid Mediators·Houli JiangJohn C McGiff
Mar 31, 2005·The Journal of Pharmacology and Experimental Therapeutics·Xiang FangArthur A Spector
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Christophe Morisseau, Bruce D Hammock
Jul 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kara R SchmelzerBruce D Hammock
Aug 12, 2005·American Journal of Physiology. Renal Physiology·John D Imig
Nov 1, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Brandon T LarsenDavid D Gutterman
Nov 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yi LiuJohn Y-J Shyy
Jul 22, 2006·Circulation Research·John M SeubertDarryl C Zeldin
Nov 30, 2006·Annals of the New York Academy of Sciences·Michelle Rodriguez, Michael Clare-Salzler
Jan 4, 2007·Hypertension·William B Campbell, John R Falck
Apr 5, 2007·Cell Biochemistry and Biophysics·David LochLindsay Brown
Apr 19, 2007·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Wenri ZhangNabil J Alkayed
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ding AiYi Zhu
Jun 15, 2007·British Journal of Pharmacology·H JiangJ C McGiff
Sep 20, 2007·Journal of Cardiovascular Pharmacology·Nipavan ChiamvimonvatBruce D Hammock
Oct 26, 2007·Trends in Endocrinology and Metabolism : TEM·Randy S SpragueMary L Ellsworth
Mar 4, 2008·Basic & Clinical Pharmacology & Toxicology·Sarbani GhoshSteven L Roberds
Oct 15, 2008·Journal of Pediatric Gastroenterology and Nutrition·Robert C De LisleKyle Jansson
Jan 1, 2007·The Open Drug Metabolism Journal·Ahmed EnayetallahDavid F Grant

❮ Previous
Next ❯

Citations

Nov 7, 2015·Analytical Chemistry·Martin A RossottiGualberto G Gonzalez-Sapienza
Aug 12, 2015·Purinergic Signalling·Geoffrey Burnstock
Jun 3, 2014·Pharmacology & Therapeutics·Payman ShahabiSophie Visvikis-Siest
Feb 3, 2012·Physiological Reviews·John D Imig
Nov 19, 2015·Frontiers in Molecular Biosciences·Ronald Sluyter
Dec 18, 2015·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ryan L HoilandPhilip N Ainslie
Jul 16, 2019·Physiological Reports·Benjamin GollaschFriedrich C Luft
Jul 10, 2020·The Journal of International Medical Research·Yunxue BaiRui Zhao
Jun 15, 2019·Cardiovascular Research·John PernowZhichao Zhou
Jun 21, 2020·Physiological Reports·Benjamin GollaschFriedrich C Luft
Nov 30, 2019·Physiological Reports·Benjamin GollaschFriedrich C Luft
Mar 15, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Houli JiangMairead A Carroll
Oct 29, 2020·Physiological Reports·Benjamin GollaschFriedrich C Luft

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.